ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 6 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 25,000 | $156,000 | 0.11% |
| Golden Green, Inc. | 19,967 | $125,000 | 0.10% |
| ARK Investment Management | 349,308 | $2,183,000 | 0.01% |
| Compagnie Lombard Odier SCmA | 43,000 | $247,000 | 0.01% |
| Belvedere Trading LLC | 17,800 | $98,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $81,000 | 0.00% |
| Renaissance Technologies | 67,689 | $423,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,296 | $21,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 12,204 | $76,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |